Ethiopia Pharmaceuticals & Healthcare Q4 2018
Ethiopia presents a high-risk pharmaceutical market for multinational drugmakers, yet offers greater long-termpotential on the back of its sizable population and foothold in East Africa. Ethiopia's government is strongly committed to improvingthe operating environment to attract foreign investment, particularly from China, which combined with a budding manufacturingsector bodes well for foreign drugmaker appetite. Over the near-term, multinational drugmaker investment in the sector will remainlimited due to the lack of high-end revenue earning opportunities and elevated country risks.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook